View All

All Publications for Health Care and Life Sciences

A NERA Briefing: Expert Workshop on HTA	Brief 2007-12-13
Key Factors in Attracting Internationally Mobile Investments by the Research-Based Pharmaceutical Industry	Report 2007-09-21	By Dr. Richard Rozek et al.
The Intellectual Property Debate: Perspectives from Law, Economics and Political Economy	Book 2006-08-01	Contributions by Dr. Richard Rozek
Competition and Innovation in Health Care Markets and Their Implications for Antitrust Enforcement	Published Article 2005-03-01	By Dr. Lawrence Wu with former NERA Senior Consultant Dr. Rika Mortimer
Antitrust Treatment of Mergers Involving Future Goods	Published Article 2004-12-31	By Richard T. Rapp with Ilene Knable Gotts, Partner at Wachtell, Lipton Rosen & Katz
Economic Issues Raised in the FDA’s Proposed Rule on Removing the Essential-Use Designation for Albuterol MDIs	Report 2004-08-13	By Dr. Richard Rozek et al.
Using In-country Comparables to Measure the Returns Due Pharmaceutical Marketing and Distribution Affiliates	Published Article 2003-12-01	By Dr. Richard Rozek et al.
Investment Incentives Created by the Montreal Protocol and FDA Policy on Albuterol	Published Article 2003-11-20	By Dr. Richard Rozek et al.
The Impact on Patients and Payers of Designating Albuterol a Non-Essential Use of an Ozone Depleting Substance	Regulatory Filing 2003-09-09	By Dr. Richard Rozek with former NERA Consultant Emily Bishko Radel
Geographic Market Issues in Hospital Mergers	Published Article 2003-06-30	By Dr. Thomas McCarthy and Dr. Scott Thomas
< Back 1 2 3 4 Next >

NERA Economic Consulting

All Publications for Health Care and Life Sciences